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Rosacea fulminans (RF), previously known as pyoderma faciale, is a rare presentation of rosacea mostly seen in young women. RF
is seen very rarely in men. We present below a case of a fifty-year-old male who presented with RF and was successfully treated
with a combination of corticosteroids and isotretinoin.

1. Introduction
Rosacea fulminans was first reported in 1940 by O’Liery and
Kierland of the Mayo Clinic in Rochester, Minnesota. We
present below a rare presentation of RF in a man, his clinical
course, and response to treatment.

2. Case Report
A fifty-year-old man presented with the sudden onset of a
diffuse facial rash. He had a several years’ history of rosacea,
well controlled with only topical treatments with the last
outbreak approximately two years prior to his presentation.
His medical history included diabetes mellitus for which he
took metformin. A review of system was positive only for
dryness in the left eye.
Physical exam revealed indurated, erythematous plaques
covering most of his forehead, bilateral cheeks, including
the nasolabial folds, nose, and chin. Numerous pustules and
erythematous papules were also present. No cysts were noted
on exam; and his back, chest, arms, and neck were spared. The
affected areas were sharply demarcated from the unaffected
areas (Figures 1 and 2). Mild erythema was seen in the medial
sclera of his left eye.
His CBC and CMP were normal and his ANA titer was
negative. A culture of his pustule returned no growth.
Hematoxylin-eosin staining showed granulomatous perifolliculitis and spongiosis with crusting. There was a heavy

folliculocentric infiltrate of lymphocytes and histiocytes in
the upper to mid dermis (Figures 3 and 4). This abrupt presentation, history of rosacea, physical exam findings, absence
of any growth in his pustules, and the histopathology supported a diagnosis of rosacea fulminans (RF).
He was started on prednisone 40 mg daily along with
risedronate 35 mg once a week, omeprazole 20 mg once a day,
and calcium and vitamin D supplements. Isotretinoin 20 mg
per day was added to his regimen three weeks after starting
prednisone. Once on isotretinoin, prednisone was tapered
down by 5 mg every week. When prednisone was tapered to
30 mg daily, isotretinoin was increased to 40 mg daily. Prednisone was then tapered over the next three weeks. We
treated the patient to a goal of 150 mg/kg of isotretinoin over
a five-month period. He had an excellent clinical response:
clearance was seen by month two of the initiation of isotretinoin treatment. Three months after treatment completion, the patient required only topical metronidazole cream
and sunscreen for maintenance of his rosacea.

3. Discussion
Kligman et al., in 1992, proposed renaming the disease, until
then called pyoderma faciale, to rosacea fulminans since the
progression of disease closely resembles acne fulminans; and
similar to acne fulminans it presents with papules, pustules,
and nodules [1]. It can be easily distinguished from acne
vulgaris by the rapidity of its appearance and its fulminant
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Figure 3: Hematoxylin-eosin biopsy specimen showing dense
folliculocentric lymphohistiocytic infiltrate with a pustule and a
demodex mite (40x).

Figure 1: Initial presentation demonstrating indurated, erythematous plaques covering most of his forehead, cheeks, nose, and chin.

Figure 4: Further magnification highlights the folliculocentric
inflammation (100x).

Figure 2: Profile view demonstrating erythematous, indurated
papules and plaques as well as pustules with a sharp demarcation
of the erythema to surrounding normal skin.

course and by the rarity of comedones [2]. A patient with RF
also tends to give a history of oily skin or seborrhea, which
may help with the initial diagnosis [1, 2]. The majority of RF
presentations are seen in women and very rarely in men [3].
While it predominantly affects the face, it can rarely affect
regions just below the face [1].
Histologically, the presentation includes an extensive
perifollicular inflammatory infiltrate, composed of a mixture
of lymphocytes, histiocytes, and polymorphonuclear leukocytes. Necrosis of the connective tissue with extension to the
surrounding tissues and into the pilosebaceous units, loss of
collagen bundles and elastic tissue, and foreign body giant cell
reaction have also been reported [4].

One mechanism proposed for the development of RF
includes cytokine-mediated inflammation triggered by sebocytes [5]. However, outbreaks have been reported in a variety
of pathophysiological settings: after ingestion of high dose
vitamin B supplements [6]; with Crohn’s disease and ulcerative colitis [7]; and during pregnancy [8].
The suggested treatment course includes systemic corticosteroids followed by isotretinoin. Topical corticosteroids
can be useful adjuvants. Amongst all presentations of rosacea,
RF is the only clinical setting when oral or topical corticosteroids are recommended [2]. Isotretinoin, in addition to its
anti-inflammatory effects, is effective in RF through its antiseborrheic effects [9].
As an alternative to isotretinoin either macrolides or
tetracyclines have effect through their anti-inflammatory
properties [10]. Subantimicrobial dosing of doxycycline has
also been shown to be effective in treating RF with extrafacial
lesions [3]. During pregnancy, RF has been demonstrated to
respond well to treatment with azithromycin [8]. In instances
where the combination of corticosteroids and isotretinoin
was ineffective, dapsone, through its anti-inflammatory properties, has been reported to be effective [5].
The combination of corticosteroids and isotretinoin
remains the first-line treatment modality for RF [10]. It was
highly effective in our patient and no recurrence has been
reported as of submission of this case report.
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